Back to the Top


Strength in Numbers: Networking for an ALS Treatment

In October 2011, clinicians and some people with amyotrophic lateral sclerosis (ALS) gathered for an unusual conference in Fort Lauderdale, Florida. They were the Northeast ALS Consortium, or NEALS, which has grown to be a U.S.-Canadian-European powerhouse in ALS clinical trials. The collaborative has tested varied trial designs, hunted for biomarkers to make those trials work better, and consistently shared data and resources to boost ALS research. The meeting aimed to expand its patient outreach with projects such as an educational retreat.